Searchable abstracts of presentations at key conferences in endocrinology
Previous issue | Volume 13 | SFEBES2007 | Next issue

Society for Endocrinology BES

Clinical Management Workshops

Differentiated thyroid cancer

ea0013s57 | Differentiated thyroid cancer | SFEBES2007

Clinical management of thyroid cancer: new guidelines

Perros Petros

Thyroid cancer is generally associated with a good prognosis, yet mortality in the UK was reported to be higher than other developed countries, and published audits have highlighted deficiencies in management of this condition in Scotland and England. The British Thyroid Association (BTA) responded by publishing national guidelines for the management of differentiated thyroid cancer in 2002. Since then, other guidelines and consensus statements have been published from Europe ...

ea0013s58 | Differentiated thyroid cancer | SFEBES2007

Surgical management of differentiated thyroid cancer (DTC)

Harrison Barney

The aims of effective surgical treatment of DTC are the provision of local control, the prevention of loco-regional relapse and when required the facilitation of adjuvant radioiodine therapy.Best practice involves a requirement to tailor the extent of thyroid and lymph node surgery to the risk of local and systemic relapse and the avoidance of over treatment and morbidity related to the laryngeal nerves and parathyroid glands. A preoperative diagnosis of...

ea0013s59 | Differentiated thyroid cancer | SFEBES2007

An update in the management practices of thyroid cancer and the use of rhTSH

Schlumberger Martin

The quality of life of thyroid cancer patients is improved with the use of recombinant human TSH (rhTSH) that avoids hypothyroidism, provides an effective stimulation of any thyroid tissue and does not increase the global cost of treatment and follow-up. Several consensus and guidelines have recently delineated indications for using rhTSH.Post-operative radioiodine administration is not indicated for very low risk tumors (<1 cm, unifocal, intrathyroi...